Clock-Enhancing Small Molecules and Potential Applications in Chronic Diseases and Aging

Area of Science:

• Chronobiology and molecular medicine
• Aging research
• Pharmacology

Background:

• Circadian clocks are essential for normal physiology; their dysregulation is linked to chronic diseases and accelerated aging.
• Targeting the circadian clock with novel compounds is an emerging therapeutic strategy.
• Circadian amplitude dampening correlates with disease progression, highlighting the need for clock-enhancing interventions.

Purpose of the Study:

• To review the circadian oscillator, its regulatory mechanisms, and the potential of clock-enhancing small molecules (CEMs) as chronotherapeutics.
• To explore the therapeutic potential of CEMs for conditions associated with circadian disruption, such as mood disorders and aging.
• To discuss nobiletin as a proof-of-principle example of a CEM targeting the circadian oscillator.

Main Methods:

• Review of existing literature on circadian clock mechanisms and amplitude regulation.
• Analysis of the association between circadian amplitude dampening and disease.
• Discussion of small molecules targeting the circadian clock, with a focus on nobiletin.

Main Results:

• Circadian clock dysregulation leads to pathological consequences including chronic diseases and accelerated aging.
• Clock-enhancing small molecules (CEMs) are identified as potential chronotherapeutics.
• Nobiletin, a natural flavonoid, demonstrates direct targeting of the circadian oscillator with metabolic benefits in mice.

Conclusions:

• CEMs offer a promising therapeutic avenue for correcting dysregulated circadian rhythms.
• Targeting the circadian clock may mitigate symptoms of mood disorders and age-related decline.
• Further research into CEMs will elucidate circadian clock regulation and its disease relevance.